Table 1.

Clinical characteristics of HCC patients

VariablesResults
No. patients71
Age, y (median, range)48, 23–75
Gender (male/female)65/6 (92/8)
HBsAg (negative/positive)8/63 (11/89)
Cirrhosis (absent/present)16/55 (23/77)
ALT, units/L (median, range)40, 11–179
AFP, ng/mL (≤25/>25)27/44 (38/62)
Tumor size, cm (≤5/>5)36/35 (51/49)
Tumor multiplicity (solitary/multiple)63/8 (89/11)
Vascular invasion (absent/present)69/2 (91/9)
Intrahepatic metastasis (no/yes)68/3 (96/4)
TNM stage (I + II/III + IV)57/14 (80/20)
Tumor differentiation (I + II/III + IV)58/13 (82/18)
Fibrous capsule (absent/present)13/58 (18/82)
B7-H1+ cells (median, range)94, 16–227
  • NOTE: Data in parentheses are percentages.

    Abbreviations: HBsAg, hepatitis B surface antigen; AFP, α-fetoprotein; ALT, alanine aminotransferase; TNM, tumor-node-metastasis.